Posted in | News | Graphene

Developer of Cost-Effective Graphene Manufacturing Methodology, Garmor, Receives Florida Institute Funds

The Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with Garmor, Inc., an advanced materials company based in Orlando, Florida that focuses on developing low-cost, low-weight and high-strength materials without sacrificing critical features such as product durability, efficiency and performance.

The Institute works with Florida’s research universities and institutions to support new company creation and job growth. The Seed Capital Accelerator Program bridges early funding gaps, requiring recipients to raise private matching investment which enables them to reach critical development milestones and get to market quicker.

Garmor has developed a cost-effective method of producing high-quality graphene, a carbon-based material similar to carbon nanotubes and fullerenes. Although graphene was discovered nearly ten years ago, attempts to commercialize the mass production of graphene have not yet achieved affordable price points for many applications. By leveraging a new manufacturing methodology, Garmor plans to initially market its graphene for use in high-volume industries. One particular industry of interest is the reinforced materials markets where graphene adds substantial material improvements. Examples where this technology will be leveraged includes thermoplastics, thermoset plastics, resins and fiberglass composites. The enhanced strength, reduced cost and ultra-lightweight features of Garmor’s graphene in graphene-reinforced materials also facilitate its use in a wide number of transportation and construction applications.

“Through sponsored research at UCF, Garmor demonstrated and proved that when used as an additive its graphene improves several material properties of composite materials. This funding, combined with our private investment, enables us to focus on volume manufacturing and customized product development,” said Anastasia Canavan, President and CEO of Garmor. “I can’t emphasize enough the importance of seed funding for companies like Garmor that are commercializing university technologies.”

“Garmor is a great example of a Florida-based company leveraging advancements in technology, in this case the discovery of graphene, to enable corporations across multiple industries to deploy better products more cost-effectively," said Jamie Grooms, Institute CEO. “Florida universities and research institutions are making new discoveries every day, improving every aspect of how we live, work and play.”

Comments

  1. Barry Dennis Barry Dennis United States says:

    Graphene is one of THE materials opportunities of the near future. Combining all the potential opportunitires in erlectronics, manufacturing materials, applications development. coatings, solar and related opens up more doors than almost anyone can imagine. I hope that the discovery process doesn't exclude private or publically-owner for-profit companies. In many cases waiting for educational or government funding for research slows the development process. Profit opportunity is a wonderful motivaor, and commensurate with the risk, graphene offers virtually limitless potential (and profit). Hint: Suppose the raw material for lowest-cost grahpene production were (virtually) FREE? Even beyond Graphene, the potential for nano-material alloying with other high-performance potential materials also offers exciting possibilities. Nano materials research means that weare truly near the "alchemy" era, wherein many, many new and wondrous developments using nanotech will occur in every field of research.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoNano.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.